KSCP
APFCP
SIUCP-ETS
NSCRD
Articles
- Page Path
- HOME > J Korean Soc Coloproctol > Volume 20(1); 2004 > Article
-
Original Article
- Clinical Significance of Lymph Node Micrometastasis in Patients with Dukes' B Colorectal Cancer.
- Lee, Hyo Won , Jang, Yong Seog
-
Journal of the Korean Society of Coloproctology 2004;20(1):57-63
- 1,315 Views
- 2 Download
- 0 Crossref
- 0 Scopus
Abstract
PURPOSE
This study aimed to provide immunohistochemical evidence of micrometastasis in patients with node-negative Dukes' B colorectal cancer and to evaluate the clinical implications, including prognostic significance, of lymphatic metastasis.
METHODS
A retrospective study of 90 patients who underwent a curative operation due to colorectal neoplasms from 1996 to 2001 was performed. Two consecutive sections of lymph nodes were prepared: one for ordinary hematoxylin-eosin staining, and the other for immunohistochemistry with pancytokeratine antibody. All clinical factors, including survival rate, were compared between patients with and without lymph-node metastasis. The mean follow- up period was 36.1 months.
RESULTS
Micrometastasis was confirmed in 115 nodes (7.9%) from 32 patients (35.6%). No correlations were observed between micrometastases and prognostic factors, including survival rate, except for lymphatic invasion and postoperative TNM staging. Twenty-six of the 32 (81.3%) patients with micrometastases belonged to stage T3N0M0 (P<0.003).
CONCLUSIONS
The immunohistochemical assay may be a useful way to identify micrometastasis in patients with Dukes' B colorectal neoplasms, but we were not able to demonstrate the prognostic significance of micrometastasis.
Cited- Related articles
-
- Clinical implications of radiologic criteria and prognostic factors for lateral lymph node metastasis in low rectal cancer
- Prevalence and clinical significance of evacuation disorders in patients with low anterior resection syndrome
- Evaluating prognostic significance of preoperative C-reactive protein to albumin ratio in older patients with pathological stage II or III colorectal cancer
TOP
